Glycopyrronium - DE Pharmaceuticals
DE Pharmaceuticals
Description
Antimuscarinic bronchodilator.
For the treatment of excessive respiratory secretions in palliative care by subcutaneous injection
Adult: 200 mcg every 4 hours and when required, hourly use is occasionally necessary, particularly in excessive respiratory secretions.
For the treatment of excessive respiratory secretions in palliative care by subcutaneous infusion
Adult: 0.6–1.2 mg/24 hours.
Indications
For the maintenance treatment of COPD.
Contraindications
Avoid in the case of renal impairment, pregnancy or breast feeding.
Preparations Available
Solution for injection
Sizes Available
Solution for injection
200 mcg/1 ml, 10 ampoules
600 mcg/3 ml, 10 ampoules
More on: Bronchodilators , Antimuscarinic bronchodilators